Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Opinion and Evidence in Cardiovascular Therapeutics

Opinion and Evidence in Cardiovascular Therapeutics Am J Cardiovasc Drugs 2002; 2 (4): 277-285 FROM THE WORLD LITERATURE 1175-3277/02/0004-0277/$25.00/0 © Adis International Limited. All rights reserved. Opinion and Evidence in Cardiovascular Therapeutics Contents 1. Hydrophobic Statins May Be Harmful . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 277 2. Paclitaxel-Eluting Stent Delays In-Stent Restenosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278 3. Clevidipine Beneficial in Acute Postoperative Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278 4. Is Early Statin Initiation After Acute Coronary Syndromes Beneficial? . . . . . . . http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

Opinion and Evidence in Cardiovascular Therapeutics

American Journal of Cardiovascular Drugs , Volume 2 (4) – Sep 13, 2012

Loading next page...
 
/lp/springer-journals/opinion-and-evidence-in-cardiovascular-therapeutics-eid7a11mU9

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer Journals
Copyright
Copyright © 2002 by Adis International Limited
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.2165/00129784-200202040-00009
Publisher site
See Article on Publisher Site

Abstract

Am J Cardiovasc Drugs 2002; 2 (4): 277-285 FROM THE WORLD LITERATURE 1175-3277/02/0004-0277/$25.00/0 © Adis International Limited. All rights reserved. Opinion and Evidence in Cardiovascular Therapeutics Contents 1. Hydrophobic Statins May Be Harmful . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 277 2. Paclitaxel-Eluting Stent Delays In-Stent Restenosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278 3. Clevidipine Beneficial in Acute Postoperative Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 278 4. Is Early Statin Initiation After Acute Coronary Syndromes Beneficial? . . . . . . .

Journal

American Journal of Cardiovascular DrugsSpringer Journals

Published: Sep 13, 2012

There are no references for this article.